Histopathological imaging features- versus molecular measurements-based cancer prognosis modeling

  title={Histopathological imaging features- versus molecular measurements-based cancer prognosis modeling},
  author={Sanguo Zhang and Yu Fan and Tingyan Zhong and Shuangge Ma},
  journal={Scientific Reports},
For lung and many other cancers, prognosis is essentially important, and extensive modeling has been carried out. Cancer is a genetic disease. In the past 2 decades, diverse molecular data (such as gene expressions and DNA mutations) have been analyzed in prognosis modeling. More recently, histopathological imaging data, which is a “byproduct” of biopsy, has been suggested as informative for prognosis. In this article, with the TCGA LUAD and LUSC data, we examine and directly compare modeling… 
3 Citations
Computed tomography radiomic features hold prognostic utility for canine lung tumors: An analytical study
First-order radiomic features from canine pulmonary tumors to histopathologic characteristics and outcome were correlated and completeness of excision was associated with overall survival, while higher mitotic index and histologic score were associated with shorter disease-free survival.
Gaussian graphical model‐based heterogeneity analysis via penalized fusion
This article develops a penalized fusion approach for heterogeneity analysis based on the Gaussian graphical model that applies penalization to the mean and precision matrix parameters to generate regularized and interpretable estimates.
Bayesian hierarchical finite mixture of regression for histopathological imaging‐based cancer data analysis
This study provides a new venue for FMR analysis for cancer and other complex diseases by simultaneously use two types of histopathological imaging features, which are extracted based on domain‐specific biomedical knowledge and using automated signal processing software, respectively.


Examination of Independent Prognostic Power of Gene Expressions and Histopathological Imaging Features in Cancer
This study adopts a rigorous statistical testing framework and test whether an individual gene expression measurement can improve prognosis modeling conditional on high-dimensional imaging features, and a parallel analysis is conducted reversing the roles of gene expressions and imaging features.
Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
A large, training–testing, multi-site, blinded validation study to characterize the performance of several prognostic models based on gene expression for 442 lung adenocarcinomas, providing the largest available set of microarray data with extensive pathological and clinical annotation for lungAdenocARCinomas.
Histopathological Imaging–Environment Interactions in Cancer Modeling
This study examines a biomarker of lung function as well as overall survival and can suggest an alternative way of cancer modeling that innovatively combines histopathological imaging and clinical/environmental data.
Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer Prognosis
  • Xin Luo, X. Zang, Guanghua Xiao
  • Medicine, Biology
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
  • 2017
Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer
Evaluating the prognostic value of LI in breast cancer samples using microarray-based screening for LI-associated genes showed that LI alone is not sufficient to highlight breast cancer patients with different prognosis, but for ER positive patients, high LI was associated with shorter survival times, whereas for ER negative patients,High LI is significantly associated with longer survival.
Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features
It is suggested that automatically derived image features can predict the prognosis of lung cancer patients and thereby contribute to precision oncology.
Morphological characterization of colorectal cancers in The Cancer Genome Atlas reveals distinct morphology–molecular associations: clinical and biological implications
The morphological patterns associated with alterations of immune checkpoint genes bear the potential to guide patient selection for clinical trials that target immune checkpoints in colorectal cancer, and provide directions for future studies.
A Multigene Assay Is Prognostic of Survival in Patients with Early-Stage Lung Adenocarcinoma
This real-time PCR–based prognostic model predicts overall and disease-free survival significantly better than clinical stage and tumor size in patients with early stage lung adenocarcinoma and performs especially well in Patients with stage I disease.